Type I Interferon Receptor Deficiency Prevents Murine Sjögren’s Syndrome

Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis

(2013) E. William St.Clair et al.   ARTHRITIS AND RHEUMATISM

Sjögren's syndrome – an update for dental practitioners

(2012) A. J. Carr et al.   BRITISH DENTAL JOURNAL

Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling

(2012) Seshagiri-Rao Nandula et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model

(2012) Steve Horvath et al.   ARTHRITIS RESEARCH & THERAPY

Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis

(2011) S. Vosslamber et al.   ANNALS OF THE RHEUMATIC DISEASES

Activation of the type I interferon pathway in primary Sjögrenʼs syndrome

(2011) Katerina M. Vakaloglou et al.   CURRENT OPINION IN RHEUMATOLOGY

Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren’s syndrome-like disease

(2011) S-R Nandula et al.   ORAL DISEASES

Sjögren's syndrome: studying the disease in mice

(2011) Nicolas Delaleu et al.   ARTHRITIS RESEARCH & THERAPY

Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands

(2011) Kwi Kang et al.   ARTHRITIS RESEARCH & THERAPY

Type I interferon: friend or foe?

(2010) Giorgio Trinchieri   JOURNAL OF EXPERIMENTAL MEDICINE

Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function

(2010) Umesh S. Deshmukh et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome

(2010) Michael Voulgarelis et al.   Nature Reviews Rheumatology

Peripheral blood gene expression profiling in Sjögren's syndrome

(2009) E S Emamian et al.   GENES AND IMMUNITY

IFN Regulatory Factor 5 Is Required for Disease Development in the Fc RIIB-/-Yaa and Fc RIIB-/- Mouse Models of Systemic Lupus Erythematosus

(2009) C. Richez et al.   JOURNAL OF IMMUNOLOGY

Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease

(2009) H. Agrawal et al.   JOURNAL OF IMMUNOLOGY

Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse

(2009) Cuong Q Nguyen et al.   ARTHRITIS RESEARCH & THERAPY

Biologic treatments for systemic rheumatic diseases

(2008) Y Shirota et al.   ORAL DISEASES